Even with risky survival rate, shortages of ECMO machines cost lives, study finds
For COVID patients, ECMO is a last-ditch respiratory treatment in which only about half survive. Yet a new small study suggests many lives would still have been saved if there had been more machines.
Source: usf.edu
